| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―21 |
The Systematic Review of the Interrelationship Between Covid-19 and Chronic Obstructive Pulmonary Disease (COPD): Implications, Outcomes, and Management Strategies (Review) |
B. V. Cheriyan, P. S. Gondhale-Karpe |
| 2 |
[GO] |
2024―Jan―15 |
Targeted Synthesis of New 5-Phenyl-2-[(E)-Styryl]-1H-Pyrimidin-6-One Derivatives and Their Inhibitory Activity Toward SARS-CoV-2 Major (MPRO) and Papain-Like Proteases (PLPRO) |
A. S. Rozhkova, I. P. Kodonidi, D. S. Anenko, S. D. Kirik, D. I. Pozdnyakov, V. P. Filippova, N. N. Vdovenko-Martynova |
| 3 |
[GO] |
2023―Aug―09 |
A Green, Validated and Stability Indicating UV Spectrophotometric Determination And HPLC Comparison of Covid-19 Drug Favipiravir in Tablets |
Işıl Evcil, Hüseyin Pehlivanoglu, Mehmet Boğa, Sena Caglar-Andac |
| 4 |
[GO] |
2023―Jan―12 |
New Analytical Methods for the Determination of New Anti-Viral Drug Favipiravir: A Potential Therapeutic Drug Against Covid-19 Virus, in Bulk and Dosage Forms |
Nandeesha Itigimatha, Kailash S. Chadchan, Basappa C. Yallur, Manjunatha D. Hadagali |
| 5 |
[GO] |
2022―Jan―31 |
The Effect of Phytocompounds of Medicinal Plants on Coronavirus (2019-NCOV) Infection |
Ahlem Zrig |
| 6 |
[GO] |
2021―Aug―19 |
Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database |
Arkadeep Sarkar, Debanjan Sen, Ashutosh Sharma, Ravi Kumar Muttineni, Sudhan Debnath |
| 7 |
[GO] |
2021―Jan―11 |
COVID-19: Analysis of Drug Repositioning Practice |
P. I. Savosina, D. S. Druzhilovskii, V. V. Poroikov |
